ACTIVE SUBSTANCE / INN

CLARITHROMYCIN

Brand name(s): VOQUEZNA TRIPLE PAK, BIAXIN, OMECLAMOX-PAK, BIAXIN XL, PREVPAC (COPACKAGED), LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED), CLARITHROMYCIN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA050757
ANDA206006
ACTIVE SUBSTANCE
Clarithromycin
REGULATORS
FDA
SPONSORS / MAH
ABBVIE, TAKEDA PHARMS USA, CUMBERLAND
TOTAL APPLICATIONS
9
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)ANDA206006RISINGPrescription
VOQUEZNA TRIPLE PAKNDA215152PHATHOMPrescription
PREVPAC (COPACKAGED)NDA050757TAKEDA PHARMS USADiscontinued
CLARITHROMYCINANDA203584HEC PHARMPrescription
CLARITHROMYCINANDA065178HIKMADiscontinued
OMECLAMOX-PAKNDA050824CUMBERLANDDiscontinued
BIAXINNDA050662ABBVIEDiscontinued
BIAXIN XLNDA050697ABBVIE INCDiscontinued
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)ANDA200218ANI PHARMSDiscontinued

FULL INTELLIGENCE ON CLARITHROMYCIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →